Moderna Spikevax COVID-19 Vaccine from Germany
Spikevax is an mRNA-based COVID-19 vaccine encoding the SARS-CoV-2 spike protein to elicit immune response. As a biotechnologically produced immunological product in pre-filled syringes for retail sale, it fits HTS 3002.15.00.
Duty Rate — Germany → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Maintain -70°C ultra-cold chain with validated shipping containers and temperature logs
• Submit IND or BLA documentation; declare as finished dosage form
• Beware expiry date issues leading to waste pharma classification under 3006.92